AstraZeneca Lokelma recommended for approval in EU for patients with hyperkalaemia on stable haemodialysis Medical Dialogues Bureau31 March 2020 1:05 PM ISTLokelma is a highly selective, oral potassium-removing agent currently approved in the US, EU, Canada, Hong Kong, China, Russia, and Japan for the...